mutant probe Search Results


biotinylated rna probes for mutant are oligo-are-m3/4  (Samchully Pharm Co Ltd)
90
Samchully Pharm Co Ltd biotinylated rna probes for mutant are oligo-are-m3/4
Biotinylated Rna Probes For Mutant Are Oligo Are M3/4, supplied by Samchully Pharm Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biotinylated rna probes for mutant are oligo-are-m3/4/product/Samchully Pharm Co Ltd
Average 90 stars, based on 1 article reviews
biotinylated rna probes for mutant are oligo-are-m3/4 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
agomir-mir-2113  (Ribobio co)
90
Ribobio co agomir-mir-2113
Agomir Mir 2113, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/agomir-mir-2113/product/Ribobio co
Average 90 stars, based on 1 article reviews
agomir-mir-2113 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mutant probe  (Avellino Labs)
90
Avellino Labs mutant probe
Mutant Probe, supplied by Avellino Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mutant probe/product/Avellino Labs
Average 90 stars, based on 1 article reviews
mutant probe - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
dna probes fims and mutant fims  (Qiagen)
90
Qiagen dna probes fims and mutant fims
A Competitive EMSAs of the binding of the <t>fimS</t> <t>DNA</t> fragment with phosphorylated GrpQ protein Kana fragment was used as the negative control. Representative images from three independent experiments. B Fold changes of the fimS DNA fragment in the GrpQ-ChIP sample relative to the mock-ChIP sample. Data were obtained from three independent experiments and presented as mean ± SD. P values were determined using a two-way analysis of variance. C DNase I footprinting assay identified precise GrpQ binding sites on fimS . The protected region shows a significantly reduced peak intensity (blue) pattern compared with that of the control (red). D Competitive EMSAs of the binding of purified phosphorylated GrpQ to the mutant fimS binding region. Representative images from three independent experiments. E Quantification of the percentage of bacteria with fimS in the phase-OFF orientation. F Phase-OFF orientation of fimS was calculated using qPCR in Δ grpP/grpQ relative to WT. Data were obtained from three independent experiments and presented as mean ± SD ( B , E, and F ). P values were determined using two-way analysis of variance ( B ) or two-tailed Student’s t -test ( E and F ). Significance was indicated by a P value. n.s., No significant difference. B P = 0.00004; F P = 0.000099. Source data are provided as a Source data file.
Dna Probes Fims And Mutant Fims, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dna probes fims and mutant fims/product/Qiagen
Average 90 stars, based on 1 article reviews
dna probes fims and mutant fims - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mutant probe  (Purigo Biotech Inc)
90
Purigo Biotech Inc mutant probe
A Competitive EMSAs of the binding of the <t>fimS</t> <t>DNA</t> fragment with phosphorylated GrpQ protein Kana fragment was used as the negative control. Representative images from three independent experiments. B Fold changes of the fimS DNA fragment in the GrpQ-ChIP sample relative to the mock-ChIP sample. Data were obtained from three independent experiments and presented as mean ± SD. P values were determined using a two-way analysis of variance. C DNase I footprinting assay identified precise GrpQ binding sites on fimS . The protected region shows a significantly reduced peak intensity (blue) pattern compared with that of the control (red). D Competitive EMSAs of the binding of purified phosphorylated GrpQ to the mutant fimS binding region. Representative images from three independent experiments. E Quantification of the percentage of bacteria with fimS in the phase-OFF orientation. F Phase-OFF orientation of fimS was calculated using qPCR in Δ grpP/grpQ relative to WT. Data were obtained from three independent experiments and presented as mean ± SD ( B , E, and F ). P values were determined using two-way analysis of variance ( B ) or two-tailed Student’s t -test ( E and F ). Significance was indicated by a P value. n.s., No significant difference. B P = 0.00004; F P = 0.000099. Source data are provided as a Source data file.
Mutant Probe, supplied by Purigo Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mutant probe/product/Purigo Biotech Inc
Average 90 stars, based on 1 article reviews
mutant probe - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
primers and probes for mutant f795f  (LSI Medience Corporation)
90
LSI Medience Corporation primers and probes for mutant f795f
A Competitive EMSAs of the binding of the <t>fimS</t> <t>DNA</t> fragment with phosphorylated GrpQ protein Kana fragment was used as the negative control. Representative images from three independent experiments. B Fold changes of the fimS DNA fragment in the GrpQ-ChIP sample relative to the mock-ChIP sample. Data were obtained from three independent experiments and presented as mean ± SD. P values were determined using a two-way analysis of variance. C DNase I footprinting assay identified precise GrpQ binding sites on fimS . The protected region shows a significantly reduced peak intensity (blue) pattern compared with that of the control (red). D Competitive EMSAs of the binding of purified phosphorylated GrpQ to the mutant fimS binding region. Representative images from three independent experiments. E Quantification of the percentage of bacteria with fimS in the phase-OFF orientation. F Phase-OFF orientation of fimS was calculated using qPCR in Δ grpP/grpQ relative to WT. Data were obtained from three independent experiments and presented as mean ± SD ( B , E, and F ). P values were determined using two-way analysis of variance ( B ) or two-tailed Student’s t -test ( E and F ). Significance was indicated by a P value. n.s., No significant difference. B P = 0.00004; F P = 0.000099. Source data are provided as a Source data file.
Primers And Probes For Mutant F795f, supplied by LSI Medience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primers and probes for mutant f795f/product/LSI Medience Corporation
Average 90 stars, based on 1 article reviews
primers and probes for mutant f795f - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mutant are probes  (ACGT Inc)
90
ACGT Inc mutant are probes
A Competitive EMSAs of the binding of the <t>fimS</t> <t>DNA</t> fragment with phosphorylated GrpQ protein Kana fragment was used as the negative control. Representative images from three independent experiments. B Fold changes of the fimS DNA fragment in the GrpQ-ChIP sample relative to the mock-ChIP sample. Data were obtained from three independent experiments and presented as mean ± SD. P values were determined using a two-way analysis of variance. C DNase I footprinting assay identified precise GrpQ binding sites on fimS . The protected region shows a significantly reduced peak intensity (blue) pattern compared with that of the control (red). D Competitive EMSAs of the binding of purified phosphorylated GrpQ to the mutant fimS binding region. Representative images from three independent experiments. E Quantification of the percentage of bacteria with fimS in the phase-OFF orientation. F Phase-OFF orientation of fimS was calculated using qPCR in Δ grpP/grpQ relative to WT. Data were obtained from three independent experiments and presented as mean ± SD ( B , E, and F ). P values were determined using two-way analysis of variance ( B ) or two-tailed Student’s t -test ( E and F ). Significance was indicated by a P value. n.s., No significant difference. B P = 0.00004; F P = 0.000099. Source data are provided as a Source data file.
Mutant Are Probes, supplied by ACGT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mutant are probes/product/ACGT Inc
Average 90 stars, based on 1 article reviews
mutant are probes - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
linker scanning mutant probes x2 and x3  (Blackwell Science Ltd)
90
Blackwell Science Ltd linker scanning mutant probes x2 and x3
A Competitive EMSAs of the binding of the <t>fimS</t> <t>DNA</t> fragment with phosphorylated GrpQ protein Kana fragment was used as the negative control. Representative images from three independent experiments. B Fold changes of the fimS DNA fragment in the GrpQ-ChIP sample relative to the mock-ChIP sample. Data were obtained from three independent experiments and presented as mean ± SD. P values were determined using a two-way analysis of variance. C DNase I footprinting assay identified precise GrpQ binding sites on fimS . The protected region shows a significantly reduced peak intensity (blue) pattern compared with that of the control (red). D Competitive EMSAs of the binding of purified phosphorylated GrpQ to the mutant fimS binding region. Representative images from three independent experiments. E Quantification of the percentage of bacteria with fimS in the phase-OFF orientation. F Phase-OFF orientation of fimS was calculated using qPCR in Δ grpP/grpQ relative to WT. Data were obtained from three independent experiments and presented as mean ± SD ( B , E, and F ). P values were determined using two-way analysis of variance ( B ) or two-tailed Student’s t -test ( E and F ). Significance was indicated by a P value. n.s., No significant difference. B P = 0.00004; F P = 0.000099. Source data are provided as a Source data file.
Linker Scanning Mutant Probes X2 And X3, supplied by Blackwell Science Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/linker scanning mutant probes x2 and x3/product/Blackwell Science Ltd
Average 90 stars, based on 1 article reviews
linker scanning mutant probes x2 and x3 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
5 -biotin end-labeled sense and antisense oligonucleotides corresponding to the mutant c/ebp binding site  (Gene Probe Inc)
90
Gene Probe Inc 5 -biotin end-labeled sense and antisense oligonucleotides corresponding to the mutant c/ebp binding site
A Competitive EMSAs of the binding of the <t>fimS</t> <t>DNA</t> fragment with phosphorylated GrpQ protein Kana fragment was used as the negative control. Representative images from three independent experiments. B Fold changes of the fimS DNA fragment in the GrpQ-ChIP sample relative to the mock-ChIP sample. Data were obtained from three independent experiments and presented as mean ± SD. P values were determined using a two-way analysis of variance. C DNase I footprinting assay identified precise GrpQ binding sites on fimS . The protected region shows a significantly reduced peak intensity (blue) pattern compared with that of the control (red). D Competitive EMSAs of the binding of purified phosphorylated GrpQ to the mutant fimS binding region. Representative images from three independent experiments. E Quantification of the percentage of bacteria with fimS in the phase-OFF orientation. F Phase-OFF orientation of fimS was calculated using qPCR in Δ grpP/grpQ relative to WT. Data were obtained from three independent experiments and presented as mean ± SD ( B , E, and F ). P values were determined using two-way analysis of variance ( B ) or two-tailed Student’s t -test ( E and F ). Significance was indicated by a P value. n.s., No significant difference. B P = 0.00004; F P = 0.000099. Source data are provided as a Source data file.
5 Biotin End Labeled Sense And Antisense Oligonucleotides Corresponding To The Mutant C/Ebp Binding Site, supplied by Gene Probe Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/5 -biotin end-labeled sense and antisense oligonucleotides corresponding to the mutant c/ebp binding site/product/Gene Probe Inc
Average 90 stars, based on 1 article reviews
5 -biotin end-labeled sense and antisense oligonucleotides corresponding to the mutant c/ebp binding site - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
c322s mutant f4 labeled fluorescent probe  (FUJIFILM)
90
FUJIFILM c322s mutant f4 labeled fluorescent probe
A Competitive EMSAs of the binding of the <t>fimS</t> <t>DNA</t> fragment with phosphorylated GrpQ protein Kana fragment was used as the negative control. Representative images from three independent experiments. B Fold changes of the fimS DNA fragment in the GrpQ-ChIP sample relative to the mock-ChIP sample. Data were obtained from three independent experiments and presented as mean ± SD. P values were determined using a two-way analysis of variance. C DNase I footprinting assay identified precise GrpQ binding sites on fimS . The protected region shows a significantly reduced peak intensity (blue) pattern compared with that of the control (red). D Competitive EMSAs of the binding of purified phosphorylated GrpQ to the mutant fimS binding region. Representative images from three independent experiments. E Quantification of the percentage of bacteria with fimS in the phase-OFF orientation. F Phase-OFF orientation of fimS was calculated using qPCR in Δ grpP/grpQ relative to WT. Data were obtained from three independent experiments and presented as mean ± SD ( B , E, and F ). P values were determined using two-way analysis of variance ( B ) or two-tailed Student’s t -test ( E and F ). Significance was indicated by a P value. n.s., No significant difference. B P = 0.00004; F P = 0.000099. Source data are provided as a Source data file.
C322s Mutant F4 Labeled Fluorescent Probe, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c322s mutant f4 labeled fluorescent probe/product/FUJIFILM
Average 90 stars, based on 1 article reviews
c322s mutant f4 labeled fluorescent probe - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
nushift egr-1 kit  (Geneka Biotechnology Inc)
90
Geneka Biotechnology Inc nushift egr-1 kit
A Competitive EMSAs of the binding of the <t>fimS</t> <t>DNA</t> fragment with phosphorylated GrpQ protein Kana fragment was used as the negative control. Representative images from three independent experiments. B Fold changes of the fimS DNA fragment in the GrpQ-ChIP sample relative to the mock-ChIP sample. Data were obtained from three independent experiments and presented as mean ± SD. P values were determined using a two-way analysis of variance. C DNase I footprinting assay identified precise GrpQ binding sites on fimS . The protected region shows a significantly reduced peak intensity (blue) pattern compared with that of the control (red). D Competitive EMSAs of the binding of purified phosphorylated GrpQ to the mutant fimS binding region. Representative images from three independent experiments. E Quantification of the percentage of bacteria with fimS in the phase-OFF orientation. F Phase-OFF orientation of fimS was calculated using qPCR in Δ grpP/grpQ relative to WT. Data were obtained from three independent experiments and presented as mean ± SD ( B , E, and F ). P values were determined using two-way analysis of variance ( B ) or two-tailed Student’s t -test ( E and F ). Significance was indicated by a P value. n.s., No significant difference. B P = 0.00004; F P = 0.000099. Source data are provided as a Source data file.
Nushift Egr 1 Kit, supplied by Geneka Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nushift egr-1 kit/product/Geneka Biotechnology Inc
Average 90 stars, based on 1 article reviews
nushift egr-1 kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mutant probe  (Sangon Biotech)
90
Sangon Biotech mutant probe
A Competitive EMSAs of the binding of the <t>fimS</t> <t>DNA</t> fragment with phosphorylated GrpQ protein Kana fragment was used as the negative control. Representative images from three independent experiments. B Fold changes of the fimS DNA fragment in the GrpQ-ChIP sample relative to the mock-ChIP sample. Data were obtained from three independent experiments and presented as mean ± SD. P values were determined using a two-way analysis of variance. C DNase I footprinting assay identified precise GrpQ binding sites on fimS . The protected region shows a significantly reduced peak intensity (blue) pattern compared with that of the control (red). D Competitive EMSAs of the binding of purified phosphorylated GrpQ to the mutant fimS binding region. Representative images from three independent experiments. E Quantification of the percentage of bacteria with fimS in the phase-OFF orientation. F Phase-OFF orientation of fimS was calculated using qPCR in Δ grpP/grpQ relative to WT. Data were obtained from three independent experiments and presented as mean ± SD ( B , E, and F ). P values were determined using two-way analysis of variance ( B ) or two-tailed Student’s t -test ( E and F ). Significance was indicated by a P value. n.s., No significant difference. B P = 0.00004; F P = 0.000099. Source data are provided as a Source data file.
Mutant Probe, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mutant probe/product/Sangon Biotech
Average 90 stars, based on 1 article reviews
mutant probe - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


A Competitive EMSAs of the binding of the fimS DNA fragment with phosphorylated GrpQ protein Kana fragment was used as the negative control. Representative images from three independent experiments. B Fold changes of the fimS DNA fragment in the GrpQ-ChIP sample relative to the mock-ChIP sample. Data were obtained from three independent experiments and presented as mean ± SD. P values were determined using a two-way analysis of variance. C DNase I footprinting assay identified precise GrpQ binding sites on fimS . The protected region shows a significantly reduced peak intensity (blue) pattern compared with that of the control (red). D Competitive EMSAs of the binding of purified phosphorylated GrpQ to the mutant fimS binding region. Representative images from three independent experiments. E Quantification of the percentage of bacteria with fimS in the phase-OFF orientation. F Phase-OFF orientation of fimS was calculated using qPCR in Δ grpP/grpQ relative to WT. Data were obtained from three independent experiments and presented as mean ± SD ( B , E, and F ). P values were determined using two-way analysis of variance ( B ) or two-tailed Student’s t -test ( E and F ). Significance was indicated by a P value. n.s., No significant difference. B P = 0.00004; F P = 0.000099. Source data are provided as a Source data file.

Journal: Nature Communications

Article Title: Two-component system GrpP/GrpQ promotes pathogenicity of uropathogenic Escherichia coli CFT073 by upregulating type 1 fimbria

doi: 10.1038/s41467-025-55982-z

Figure Lengend Snippet: A Competitive EMSAs of the binding of the fimS DNA fragment with phosphorylated GrpQ protein Kana fragment was used as the negative control. Representative images from three independent experiments. B Fold changes of the fimS DNA fragment in the GrpQ-ChIP sample relative to the mock-ChIP sample. Data were obtained from three independent experiments and presented as mean ± SD. P values were determined using a two-way analysis of variance. C DNase I footprinting assay identified precise GrpQ binding sites on fimS . The protected region shows a significantly reduced peak intensity (blue) pattern compared with that of the control (red). D Competitive EMSAs of the binding of purified phosphorylated GrpQ to the mutant fimS binding region. Representative images from three independent experiments. E Quantification of the percentage of bacteria with fimS in the phase-OFF orientation. F Phase-OFF orientation of fimS was calculated using qPCR in Δ grpP/grpQ relative to WT. Data were obtained from three independent experiments and presented as mean ± SD ( B , E, and F ). P values were determined using two-way analysis of variance ( B ) or two-tailed Student’s t -test ( E and F ). Significance was indicated by a P value. n.s., No significant difference. B P = 0.00004; F P = 0.000099. Source data are provided as a Source data file.

Article Snippet: DNA probes of fimS and the mutant fimS (the binding motif was mutated to 5ʹ-CCGTGCGCTGGGTGACCGAGCATCCCCCA-3ʹ) were amplified respectively with and without 6-FAM-labeled primers and purified (QIAGEN; 28006).

Techniques: Binding Assay, Negative Control, Footprinting, Control, Purification, Mutagenesis, Bacteria, Two Tailed Test